Global Healthcare-Associated Infection (HAI) Market, By Product (Consumables, Analyzers/Instruments), Pathogen (Viral, Bacterial and Fungal), Treatment (Sterilization, Chemical, and Radiation), Infections (Urinary Tract Infections, Surgical Site Infections, Hospital-acquired Pneumonia, BloodStream Infections, Gastrointestinal Infections, Respiratory infections. Other Healthcare-associated Infections), Diagnostic Tests (Traditional Diagnostics, and Molecular Diagnostics), End Use (Hospitals, Clinics, ASCs, and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights Global Healthcare-Associated Infection (HAI) Market
The healthcare-associated infection (HAI) market is expected to witness market growth at a rate of 34.62% in the forecast period of 2022 to 2029. Data Bridge Market Research report on healthcare-associated infection (HAI) market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the healthcare sector globally is escalating the growth of healthcare-associated infection (HAI) market.
A hospital acquired infection (HAI), also known as nosocomial infection or health care associated infection (HCAI), refers to an infection that is generally acquired in a health care facility. This condition includes infections acquired in the hospital, although the effects and symptoms may appear after discharge. The health care associated infection includes occupational infection among staff of the hospital.
The increase in the incidence of hospital-acquired infections (HAIs) across the globe acts as one of the major factors driving the growth of healthcare-associated infection (HAI) market. The high focus on reducing the possibilities of infections and contamination by sterlizing the services offered by healthcare centers such are hospitals, clinics and pathologies accelerate the market growth. The increase in need of proper infection control measures in hospitals, especially in ICUs, due to the outbreak of COVID-19 pandemic, and rise in awareness of environmental and personal hygiene further influence the market. Additionally, advancements in healthcare infrastructure, high disposable income, surge in healthcare expenditure, and increase in number of surgical procedures positively affect the healthcare-associated infection (HAI) market. Furthermore, adoption of single-use medical nonwovens and devices, and increase in awareness regarding the use of personalized medicine extend profitable opportunity to the market players in the forecast period of 2022 to 2029.
On the other hand, complications associated with hospital-acquired infection control procedures, and adverse effects of treatments are expected to obstruct the market growth. Lack of awareness is projected to challenge the healthcare-associated infection (HAI) market in the forecast period of 2022-2029.
This healthcare-associated infection (HAI) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on healthcare-associated infection (HAI) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Healthcare-Associated Infection (HAI) Market Scope and Market Size
The healthcare-associated infection (HAI) market is segmented on the basis of product, pathogens, treatment, infections, diagnostic tests and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the healthcare-associated infection (HAI) market is segmented into consumables, and analyzers/instruments.
- Based on pathogens, the healthcare-associated infection (HAI) market is segmented into viral, bacterial, and fungal. Bifurcations on the basis of treatment are sterilization, chemical, and radiation.
- Based on the type of infections, healthcare-associated infection (HAI) market is segmented into urinary tract infections, surgical site infections, hospital-acquired pneumonia, bloodstream infections, gastrointestinal infections, respiratory infections and other healthcare-associated infections.
- Segmentation on the basis of diagnostics test in the healthcare-associated infection (HAI) market is traditional diagnostics, and molecular diagnostics.
- Healthcare-associated infection (HAI) market has also been segmented based on the end use into hospitals, clinics, ASCs, and others.
Healthcare-Associated Infection (HAI) Market Country Level Analysis
The healthcare-associated infection (HAI) market is segmented on the basis of product, pathogens, treatment, infections, diagnostic tests and end use.
The countries covered in the healthcare-associated infection (HAI) market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the healthcare-associated infection (HAI) market because of the high focus on healthy lifestyles and disease prevention among consumers within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the implementation of favorable government initiatives in the region.
The country section of the healthcare-associated infection (HAI) market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The healthcare-associated infection (HAI) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for healthcare-associated infection (HAI) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the healthcare-associated infection (HAI) market. The data is available for historic period 2010-2020.
Competitive Landscape and Healthcare-Associated Infection (HAI) Market Share Analysis
The healthcare-associated infection (HAI) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to healthcare-associated infection (HAI) market.
Some of the major players operating in the healthcare-associated infection (HAI) market report are HORIBA, Ltd., BD., bioMérieux, Danaher, F. Hoffmann-La Roche Ltd, Meridian Bioscience, QIAGEN, ASP, Fortive, Johnson & Johnson Services, 3M, STERIS plc., Getinge AB., Cantel Medical., Belimed, Trinity Biotech, DiaSorin, OpGen, Accelerate Diagnostics, Thermo Fisher Scientific, Bio-Rad, Luminex Corporation., and Quidel Corporation among others.